The Indian Council of Medical Research (ICMR) successfully organized its 1st Annual Clinical Trial Meet 2026 on May 20, 2026, under the theme “International Clinical Trials Day: Focus on Integrative Medicine Clinical Trials,” marking a significant milestone for India’s clinical research ecosystem. The event featured groundbreaking findings from ICMR’s multicentric Phase III trial on iron deficiency anemia, showing Ayurvedic formulations were therapeutically equivalent to standard iron-folic acid therapy in nearly 4,000 non-pregnant women.
ICMR launched two major reports: “Advancing First-in-Human Phase 1 Clinical Trials in India” and “Operational Guidelines for Single Ethics Review of Multicentre Research” to strengthen regulatory pathways and harmonize ethical reviews nationwide. India’s New Drugs and Clinical Trials (Amendment) Rules 2026 reduced approval timelines from 90 to 45 working days, significantly improving ease of doing business for pharmaceutical companies.
The 17th Annual Clinical Trials Summit 2026 is scheduled for June 10–11 at World Trade Center Mumbai, serving as India’s premier platform for exploring decentralized trials, AI-driven research, and future advancements in clinical trials.
International Updates
The United Kingdom implemented its most significant clinical trials reform in two decades on April 28, 2026, with The Medicines for Human Use (Clinical Trials) (Amendment) Regulations 2025 creating streamlined approvals through a codified Combined Review process. The reforms emphasize risk-proportionate approaches, expedited pathways for low-risk trials, and renewed focus on patient diversity and inclusion.
Global Clinical Trials Connect 2026 will convene leading experts focusing on adaptive trial designs, AI-powered analytics, and patient-centric research strategies, bringing together global leaders, clinical researchers, and technology pioneers. Euro Clinical Trials 2026 is scheduled for June 29–30, 2026 in London, UK, fostering collaboration among international clinical research experts.
International Clinical Trials Day was celebrated on May 20, 2026 worldwide with the theme “Stronger Together: Advanced Therapy Clinical Trials Without Borders,” emphasizing multinational clinical research collaboration and patient-centric approaches
The Clinical and Research Updates section monitors drug and cancer across India's pharmaceutical sector. Significant developments around patients continue to draw attention from regulators, investors, and industry professionals, reflecting the dynamic pace of change in this space.
Recent coverage has drawn from Newsweek, PsyPost, and 01net, among other publications. This section is updated as new stories emerge, ensuring readers have access to the most current information shaping this part of the pharmaceutical landscape.
For authoritative reference, World Health Organisation and CDSCO publish official guidance and regulatory documentation relevant to these topics. Peer-reviewed research and clinical data can be accessed through PharmaBiz.
Showing 20 articles
-
People with hard-to-treat depression tried a psychedelic—then symptoms changed
People with hard-to-treat depression tried a psychedelic—then symptoms changed Newsweek
-
News coverage of psilocybin often outpaces the science, systematic review finds
News coverage of psilocybin often outpaces the science, systematic review finds PsyPost
-
Omabit Announces Seed Financing to Advance Scientific Decision-Making in Drug Development
Omabit Announces Seed Financing to Advance Scientific Decision-Making in Drug Development 01net
-
ESMO26: Promising results seen for opamtistomig in advanced heavily treated epNEC
ESMO26: Promising results seen for opamtistomig in advanced heavily treated epNEC Clinical Trials Arena
-
BullFrog AI CEO Vin Singh to keynote on AI prog...
BullFrog AI CEO Vin Singh to keynote on AI prog... Pluang
-
All five patients reported improvement; a sensitive post-treatment test found no parasite in four.
All five patients reported improvement; a sensitive post-treatment test found no parasite in four. Stock Titan
-
Pharmaceutical Guest Speaker | #1 Keynote Scott Steinberg
Pharmaceutical Guest Speaker | #1 Keynote Scott Steinberg https://www.futuristsspeakers.com/
-
AI drug discovery is changing which experiments reach patients
AI drug discovery is changing which experiments reach patients Innovation News Network
-
Vanda Pharmaceuticals Announces Positive Results from Study 3601 of NEREUS™ (tradipitant) for Prevention of GLP-1-Induced Vomiting
Vanda Pharmaceuticals Announces Positive Results from Study 3601 of NEREUS™ (tradipitant) for Prevention of GLP-1-Induced Vomiting Stock Titan
-
Pfizer’s ELREXFIO Outperforms Standard Regimens and Meets Primary Endpoint in Phase 3 Study in Relapsed or Refractory Multiple Myeloma
Pfizer’s ELREXFIO Outperforms Standard Regimens and Meets Primary Endpoint in Phase 3 Study in Relapsed or Refractory Multiple Myeloma Business Wire
-
Breast Cancer Research Highlights From ESMO 2026
Breast Cancer Research Highlights From ESMO 2026 Breast Cancer.org
-
Cancer: a surge in clinical trials – how China is challenging the world with smart drugs
Cancer: a surge in clinical trials – how China is challenging the world with smart drugs Il Sole 24 ORE
-
FLAT-WHITE: from target trial emulation to federated high-throughput causal machine learning using decentralized real-world data
FLAT-WHITE: from target trial emulation to federated high-throughput causal machine learning using decentralized real-world data Nature
-
Eli Lilly Weight Loss Drug Clinical Trials: What Is Known So Far
Eli Lilly Weight Loss Drug Clinical Trials: What Is Known So Far BusinessWorld Online
-
Why a Breakthrough Blood Cancer Drug Could Be Better for Patients | Newswise
Why a Breakthrough Blood Cancer Drug Could Be Better for Patients | Newswise Newswise
-
FDA advisers narrowly vote to add 6 peptides to a drug compounding list. What's next? - ABC News
FDA advisers narrowly vote to add 6 peptides to a drug compounding list. What's next? ABC News - Breaking News, Latest News and Videos
-
FDA approves breakthrough drug to treat advanced pancreatic cancer - ABC News
FDA approves breakthrough drug to treat advanced pancreatic cancer ABC News - Breaking News, Latest News and Videos
-
VCU receives $3.8 million NIH grant to study potential heart failure therapy
VCU receives $3.8 million NIH grant to study potential heart failure therapy VCU Health
-
Incyte pancreatic cancer medicine induces lasting tumor responses, company says at ESMO
Incyte pancreatic cancer medicine induces lasting tumor responses, company says at ESMO STAT
-
Next-generation drug reduces endometrial cancer progression and death in trial
Next-generation drug reduces endometrial cancer progression and death in trial Medical Xpress